Location: United States, Texas, Austin
Investors 1
Date | Name | Website |
- | NaviMed Ca... | navimed.co... |
Mentions in press and media 20
Date | Title | Description |
13.03.2024 | Bio-Implants Market Analysis & Forecast for Next 5 Years | Johnson & Johnson, Medtronic, Stryker | Bio-Implants Bio-Implants Market will witness a 10% CAGR, Top Key Players and Forecast to 2030 Stay up to date with Bio-Implants Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.”... |
18.06.2021 | ZIMMER ENERGY TRANSITION ACQUISITION CORP. Zimmer Energy Transition Acquisition Corp. : Announces Closing of $345 Million Initial Public Offering Including Full Exercise of Underwriters' Over-Allotme... | Zimmer Energy Transition Acquisition Corp. (Nasdaq:ZTAQU) (the “Company”), a blank check company led by Stuart J. Zimmer, today announced the closing of its initial public offering of 34,500,000 units at a price of $10.00 per unit, which in... |
16.06.2021 | Zimmer Energy Transition Acquisition Corp. : Announces Pricing of $300 Million Initial Public Offering | Zimmer Energy Transition Acquisition Corp. (the “Company”), a blank check company led by Stuart J. Zimmer, today announced the pricing of its initial public offering of 30,000,000 units at a price of $10.00 per unit. The units will be liste... |
10.08.2017 | Zimmer BioTech Raises €7M in Funding | Zimmer BioTech, a Neu-Ulm, Germany-based drug development startup, raised €7m in funding. Backers included Zimmer MedizinSysteme GmbH, the medical device producer which spun off the company, and High-Tech Gründerfonds. The company will use ... |
14.04.2015 | Zimmer extends deadline for $13B Biomet deal | Zimmer (NYSE:ZMH) said today that it’s extending the "outside date" for its merger with crosstown rival Biomet by 3 months as it waits for the U.S. Federal Trade Commission to approve the $13.34 billion deal. Zimmer said it’s push... |
18.10.2013 | Zimmer gets a chance to reverse $27.6M loss over marketing video injury | Zimmer (NYSE:ZMH) will get another chance to defend itself and possibly overturn a $27.6 million verdict in favor of a knee implant patient who said she re-injured her joints while making a Zimmer promotional video. Plaintiff Margo Polett c... |
26.08.2013 | Zimmer scores 510(k) nod for device to aid surgeons with reverse arthroplasty procedures | Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
01.01.2013 | Zimmer recall gets FDA’s highest-risk Class I status | MassDevice.com On Call | MASSDEVICE ON CALL — The FDA slapped medical device giant Zimmer Holdings (NYSE:ZMH) with Class I status for a global recall of the company’s PEEK Ardis Inserter instruments over concerns that the devices could cause issues during surgery. ... |
20.12.2012 | Zimmer Spine launches urgent global recall | Medical device giant Zimmer Holdings (NYSE:ZMH) launched an urgent worldwide recall of its PEEK Ardis Inserter instruments after receiving reports that they may fracture Ardis Interbody Spacers during spinal surgery. There are about 315 uni... |
11.05.2011 | Boston Scientific CEO Ray Elliott tips his hand on possible successor | J. Raymond Elliott’s decision to step down as CEO of Boston Scientific (NYSE:BSX) began a little more than a month ago, when the company’s board asked him to document the accomplishments of his two-year tenure. As he spent an entire Sunday ... |
Show more